Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 129 articles:
HTML format
Text format



Single Articles


    May 2018
  1. HATTORI A, Suzuki K
    New era defining a novel clinical T staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2179-2180.
    PubMed     Text format    


    April 2018
  2. SWANSON SJ
    Good vibrations-better care for lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Apr 13. pii: S0022-5223(18)30994.
    PubMed     Text format    


  3. BRUNELLI A
    It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30962.
    PubMed     Text format    


  4. OKIROR L, Harling L, Toufektzian L, King J, et al
    Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30935.
    PubMed     Text format     Abstract available


  5. CAO J, Xu J, He Z, Yuan P, et al
    Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2018 Apr 6. pii: S0022-5223(18)30905.
    PubMed     Text format     Abstract available


  6. YENDAMURI S, Dhillon SS, Groman A, Dy G, et al
    Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    J Thorac Cardiovasc Surg. 2018 Apr 4. pii: S0022-5223(18)30895.
    PubMed     Text format     Abstract available


  7. MAO Q, Xia W, Dong G, Chen S, et al
    A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    J Thorac Cardiovasc Surg. 2018;155:1784-1792.
    PubMed     Text format     Abstract available


    March 2018
  8. KRUSER TJ, Mohindra N, DeCamp MM
    One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer management.
    J Thorac Cardiovasc Surg. 2018 Mar 29. pii: S0022-5223(18)30865.
    PubMed     Text format    


  9. ISBELL JM, Jones DR, Li BT
    Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30707.
    PubMed     Text format    


  10. AJMANI GS, Wang CH, Kim KW, Howington JA, et al
    Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30776.
    PubMed     Text format     Abstract available


  11. CAMERON RB
    Adherence to lung cancer surgical quality standards is critical for the survival of both our patients and our specialty.
    J Thorac Cardiovasc Surg. 2018 Mar 7. pii: S0022-5223(18)30612.
    PubMed     Text format    


  12. SU K, Gao S, Ying J, Zou S, et al
    Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B.
    J Thorac Cardiovasc Surg. 2018 Mar 6. pii: S0022-5223(18)30059.
    PubMed     Text format    


  13. ROCCO G
    Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 2. pii: S0022-5223(18)30604.
    PubMed     Text format    


  14. BRUNELLI A
    Short-term outcomes do not capture the real value of lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018;155:1311-1312.
    PubMed     Text format    


  15. MEHRAN RJ, Martin LW, Roth JA
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:1307.
    PubMed     Text format    


    February 2018
  16. SEPESI B, Ye Y, Mitchell KG, Zhang L, et al
    Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Feb 15. pii: S0022-5223(18)30372.
    PubMed     Text format     Abstract available


  17. CHENG X, Zheng D, Li Y, Li H, et al
    Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30362.
    PubMed     Text format     Abstract available


  18. MUNOZ-LARGACHA JA, Steiling KA, Kathuria H, Charlot M, et al
    Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30308.
    PubMed     Text format     Abstract available


  19. THORNBLADE LW, Wood DE, Mulligan MS, Farivar AS, et al
    Variability in invasive mediastinal staging for lung cancer: A multicenter regional study.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30311.
    PubMed     Text format     Abstract available


  20. RUSTHOVEN CG, Jones BL, Kavanagh BD
    Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:810-811.
    PubMed     Text format    


    January 2018
  21. AHMAD U, Machuzak M
    Electric shock therapy for lung cancer: Taking palliation to the next level.
    J Thorac Cardiovasc Surg. 2018 Jan 31. pii: S0022-5223(18)30245.
    PubMed     Text format    


  22. MOGHANAKI D, Simone CB 2nd, Rimner A, Karas TZ, et al
    The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:429-431.
    PubMed     Text format    


    December 2017
  23. NOMORI H, Shiraishi A, Cong Y, Shoji K, et al
    Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 26. pii: S0022-5223(17)33059.
    PubMed     Text format     Abstract available


  24. RUSCH VW, Chaft J, Hellmann M
    KEYNOTE-024: Unlocking a pathway to lung cancer cure?
    J Thorac Cardiovasc Surg. 2017 Dec 23. pii: S0022-5223(17)33029.
    PubMed     Text format    


  25. ROGERS LJ, Bleetman D, Messenger DE, Joshi NA, et al
    The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32855.
    PubMed     Text format     Abstract available


  26. DRAKE JA, Sullivan JL, Weksler B
    Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32857.
    PubMed     Text format     Abstract available


  27. DIGESU CS, Hachey KJ, Gilmore DM, Khullar OV, et al
    Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32505.
    PubMed     Text format     Abstract available


  28. BRUNELLI A
    Time of modeling survival of patients with stage III-N2 non-small cell lung cancer: Before or after surgery makes a difference.
    J Thorac Cardiovasc Surg. 2017 Dec 12. pii: S0022-5223(17)32837.
    PubMed     Text format    


    November 2017
  29. GELLER AD, Zheng H, Mathisen DJ, Wright CD, et al
    Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 20. pii: S0022-5223(17)32702.
    PubMed     Text format     Abstract available


  30. NEGRAO MV, Quek K, Zhang J, Sepesi B, et al
    TRACERx: Tracking tumor evolution to impact the course of lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 16. pii: S0022-5223(17)32689.
    PubMed     Text format    


  31. FERNANDEZ FG, Kosinski AS, Furnary AP, Onaitis M, et al
    Differential effects of operative complications on survival after surgery for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 13. pii: S0022-5223(17)32503.
    PubMed     Text format     Abstract available


  32. WEKSLER B
    Resection of pleural implants in patients with lung cancer should remain the exception rather than the rule.
    J Thorac Cardiovasc Surg. 2017 Nov 8. pii: S0022-5223(17)32459.
    PubMed     Text format    


  33. LIN J
    Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32471.
    PubMed     Text format    


  34. CHENG X, Chen H
    Commentary on the impacts of postoperative complications on survival after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32470.
    PubMed     Text format    


  35. ZHENG D, Ye T, Hu H, Zhang Y, et al
    Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 3. pii: S0022-5223(17)32409.
    PubMed     Text format     Abstract available


  36. LIU M, Wigle D, Wampfler JA, Dai J, et al
    T category of non-small cell lung cancer invading the fissure to the adjacent lobe.
    J Thorac Cardiovasc Surg. 2017;154:1777-1783.
    PubMed     Text format     Abstract available


  37. LANUTI M
    Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.
    J Thorac Cardiovasc Surg. 2017 Nov 1. pii: S0022-5223(17)32392.
    PubMed     Text format    


    October 2017
  38. MOLENA D
    Shining light on sentinel node assessment for lung cancer: Quality is superior to quantity.
    J Thorac Cardiovasc Surg. 2017 Oct 20. pii: S0022-5223(17)32331.
    PubMed     Text format    


    September 2017
  39. DETTERBECK FC
    The eighth edition TNM stage classification for lung cancer: What does it mean on main street?
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32136.
    PubMed     Text format    


  40. ZHANG Z, Mostofian F, Ivanovic J, Gilbert S, et al
    All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32135.
    PubMed     Text format     Abstract available


  41. TURNA A, Melek H, Kara HV, Kilic B, et al
    Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Sep 27. pii: S0022-5223(17)32131.
    PubMed     Text format     Abstract available


  42. CERFOLIO RJ, Ghanim AF, Dylewski M, Veronesi G, et al
    The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.
    J Thorac Cardiovasc Surg. 2017 Sep 18. pii: S0022-5223(17)31919.
    PubMed     Text format     Abstract available


  43. GILBERT CR, Ely R, Fathi JT, Louie BE, et al
    The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
    J Thorac Cardiovasc Surg. 2017 Sep 13. pii: S0022-5223(17)31890.
    PubMed     Text format     Abstract available


  44. SEDER CW
    Lung cancer screening is here to stay, but does it pay?
    J Thorac Cardiovasc Surg. 2017 Sep 12. pii: S0022-5223(17)31887.
    PubMed     Text format    


  45. ANTONOFF MB
    Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?
    J Thorac Cardiovasc Surg. 2017 Sep 8. pii: S0022-5223(17)31866.
    PubMed     Text format    


  46. TONG BC
    Lung cancer screening: No more excuses.
    J Thorac Cardiovasc Surg. 2017 Sep 5. pii: S0022-5223(17)31853.
    PubMed     Text format    


  47. LIU C, Liu L
    Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134.
    PubMed     Text format    


  48. DIGESU CS, Colson YL
    A "green" light for staging in early lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134-1136.
    PubMed     Text format    


  49. FLORES RM
    Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31820.
    PubMed     Text format    


  50. KIDANE B
    Stereotactic body radiation therapy versus video-assisted thoracoscopic surgery in stage I lung cancer: Honesty in the face of uncertainty.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31821.
    PubMed     Text format    


  51. HATTORI A, Matsunaga T, Takamochi K, Oh S, et al
    Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31798.
    PubMed     Text format     Abstract available


  52. BURT BM
    Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31823.
    PubMed     Text format    


    August 2017
  53. CORNWELL LD, Echeverria AE, Samuelian J, Mayor J, et al
    Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    J Thorac Cardiovasc Surg. 2017 Aug 16. pii: S0022-5223(17)31718.
    PubMed     Text format     Abstract available


    July 2017
  54. FERNANDEZ FG
    What are the gaps in quality measurement for lung cancer surgery?
    J Thorac Cardiovasc Surg. 2017 Jul 1. pii: S0022-5223(17)31367.
    PubMed     Text format    


    June 2017
  55. SCHAHEEN LW, D'Cunha J
    The slippery slope of nonoperative therapy in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Jun 10. pii: S0022-5223(17)31178.
    PubMed     Text format    


  56. BRANDT WS, Isbell JM, Jones DR
    Defining quality in the surgical care of lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31171.
    PubMed     Text format    


    May 2017
  57. CHEN K, Zhang J, Guan T, Yang F, et al
    Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 24. pii: S0022-5223(17)31084.
    PubMed     Text format     Abstract available


  58. ZHAO Y, Li G, Zhang Y, Hu H, et al
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 20. pii: S0022-5223(17)31049.
    PubMed     Text format     Abstract available


  59. NGUYEN DM, Villamizar N
    "One-stop shop" tumor tattooing and sentinel lymph node mapping: A new paradigm for lung cancer therapy.
    J Thorac Cardiovasc Surg. 2017 May 17. pii: S0022-5223(17)30908.
    PubMed     Text format    


    April 2017
  60. WEKSLER B
    One in every 14 patients with early-stage lung cancer is not being treated!
    J Thorac Cardiovasc Surg. 2017 Apr 24. pii: S0022-5223(17)30850.
    PubMed     Text format    


  61. HOANG CD
    Protein-based prognostic biomarkers in lung cancer: Promise or pitfall?
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30851.
    PubMed     Text format    


  62. FERRARIS VA
    Interstitial lung disease and lung cancer: Decisions, precision, and tuna fish sandwiches.
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30848.
    PubMed     Text format    


  63. BURT BM
    Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?
    J Thorac Cardiovasc Surg. 2017 Apr 12. pii: S0022-5223(17)30689.
    PubMed     Text format    


  64. BERRY MF
    Evidence for resection of sarcoma pulmonary metastases: More, but better?
    J Thorac Cardiovasc Surg. 2017 Apr 7. pii: S0022-5223(17)30658.
    PubMed     Text format    


  65. MCMURRY TL, Shah PM, Samson P, Robinson CG, et al
    Treatment of stage I non-small cell lung cancer: What's trending?
    J Thorac Cardiovasc Surg. 2017 Apr 5. pii: S0022-5223(17)30643.
    PubMed     Text format     Abstract available


  66. YEROKUN BA, Yang CJ, Gulack BC, Li X, et al
    A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30639.
    PubMed     Text format     Abstract available


  67. TSUTANI Y, Mimura T, Kai Y, Ito M, et al
    Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30635.
    PubMed     Text format     Abstract available


  68. SMELTZER MP, Lin CC, Kong FS, Jemal A, et al
    Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30604.
    PubMed     Text format     Abstract available


    February 2017
  69. HACHEY KJ, Digesu CS, Armstrong KW, Gilmore DM, et al
    A novel technique for tumor localization and targeted lymphatic mapping in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Feb 10. pii: S0022-5223(17)30190.
    PubMed     Text format     Abstract available


  70. CZARNECKA-KUJAWA K, Rochau U, Siebert U, Atenafu E, et al
    Cost-effectiveness of mediastinal lymph node staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Feb 9. pii: S0022-5223(17)30176.
    PubMed     Text format     Abstract available


  71. BURT BM
    Clarity and clairvoyance: Review and prediction of management guidelines for early stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Feb 8. pii: S0022-5223(17)30170.
    PubMed     Text format    


    January 2017
  72. BURT BM
    Thoracoscopic lobectomy for clinical N2 and N1 lung cancer: Innovation outpacing standard of care.
    J Thorac Cardiovasc Surg. 2017 Jan 10. pii: S0022-5223(17)30004.
    PubMed     Text format    


    December 2016
  73. CHEN K, Wang X, Yang F, Li J, et al
    Propensity-matched comparison of video-assisted thoracoscopic with thoracotomy lobectomy for locally advanced non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2016 Dec 15. pii: S0022-5223(16)31671.
    PubMed     Text format     Abstract available


  74. ROCCO G
    Hear! Hear! Against alLODDS, we might have a LiNeaR predictive model for prognosis of non-small cell lung cancer from pN+ nodal status.
    J Thorac Cardiovasc Surg. 2016 Dec 12. pii: S0022-5223(16)31668.
    PubMed     Text format    


  75. BAISI A, Raveglia F, Cioffi U
    Does N2 frozen section make sense in cN0 non-small cell lung cancer patients?
    J Thorac Cardiovasc Surg. 2016;152:1642-1643.
    PubMed     Text format    


    November 2016
  76. SHETTY PS, Mankar H, Pramesh CS
    Management of N2 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2016;152:1463-1464.
    PubMed     Text format    


    October 2016
  77. PAGES PB, Mordant P, Renaud S, Brouchet L, et al
    Sleeve lobectomy may provide better outcomes than pneumonectomy for non-small cell lung cancer. A decade in a nationwide study.
    J Thorac Cardiovasc Surg. 2016 Oct 13. pii: S0022-5223(16)31275.
    PubMed     Text format     Abstract available


    August 2016
  78. DARLING GE
    Narcissus, the beam and lung cancer: What is the message?
    J Thorac Cardiovasc Surg. 2016;152:344.
    PubMed     Text format    


    July 2016
  79. KIM S
    Role of metformin in lung cancer treatment and prevention: Are we any closer to the answer?
    J Thorac Cardiovasc Surg. 2016;152:62-3.
    PubMed     Text format    


  80. ONAITIS MW, Salama J
    Surgery versus stereotactic body radiation therapy for operable stage I non-small cell lung cancer: Can we achieve equipoise?
    J Thorac Cardiovasc Surg. 2016;152:1-2.
    PubMed     Text format    


    June 2016
  81. YANG SC
    Appropriate lung cancer treatments: A missed opportunity . . . or an opportunity to modify?
    J Thorac Cardiovasc Surg. 2016;151:1559-60.
    PubMed     Text format    


  82. BOTT MJ, Patel AP, Verma V, Crabtree TD, et al
    Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?
    J Thorac Cardiovasc Surg. 2016;151:1549-1558.
    PubMed     Text format     Abstract available


  83. LIBERMAN M
    Cleaning the pipes before changing the furnace: Endoscopic patient optimization before major therapeutic intervention in lung cancer.
    J Thorac Cardiovasc Surg. 2016 Jun 1. pii: S0022-5223(16)30476.
    PubMed     Text format    


    May 2016
  84. WU G, Li Z, Jiao D, Han X, et al
    Sequential interventional treatment of right-sided lung cancer with complete lung atelectasis: A case report.
    J Thorac Cardiovasc Surg. 2016 May 11. pii: S0022-5223(16)30320.
    PubMed     Text format    


  85. ROCCO G
    Narcissus, the Beam, and lung cancer.
    J Thorac Cardiovasc Surg. 2016 May 2. pii: S0022-5223(16)30286.
    PubMed     Text format     Abstract available


    April 2016
  86. MEDAIROS RA, Clark J, Holoubek S, Kubasiak JC, et al
    Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2016 Apr 14. pii: S0022-5223(16)30117.
    PubMed     Text format     Abstract available


  87. ROSEN JE, Salazar MC, Wang Z, Yu JB, et al
    Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
    J Thorac Cardiovasc Surg. 2016 Apr 7. pii: S0022-5223(16)30035.
    PubMed     Text format     Abstract available


  88. FINLEY C
    The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries.
    J Thorac Cardiovasc Surg. 2016;151:1219.
    PubMed     Text format    


  89. BACIWEICZ FA JR
    Surgeon volume and procedure selection.
    J Thorac Cardiovasc Surg. 2016;151:1218-9.
    PubMed     Text format    


  90. RAJA S, Blackstone EH, Murthy SC
    Caught between a rock and a hard place: Venous thromboembolism screening in high-risk patients.
    J Thorac Cardiovasc Surg. 2016;151:1000-1.
    PubMed     Text format    


  91. NASON KS
    Is there a role for postinduction positron emission tomography and computed tomography with fludeoxyglucose F 18? A call for standardization.
    J Thorac Cardiovasc Surg. 2016;151:980-1.
    PubMed     Text format    


  92. AGZARIAN J, Hanna WC, Schneider L, Schieman C, et al
    Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem.
    J Thorac Cardiovasc Surg. 2016;151:992-9.
    PubMed     Text format     Abstract available



  93. Discussion.
    J Thorac Cardiovasc Surg. 2016;151:978-9.
    PubMed     Text format    


    March 2016
  94. WANG L, Cao T, Li X, Huang L, et al
    Three-dimensional printing titanium ribs for complex reconstruction after extensive posterolateral chest wall resection in lung cancer.
    J Thorac Cardiovasc Surg. 2016 Mar 12. pii: S0022-5223(16)00420.
    PubMed     Text format    


  95. WANG X, Berry MF
    Risk calculators are useful but....
    J Thorac Cardiovasc Surg. 2016;151:706-7.
    PubMed     Text format    



  96. Discussion.
    J Thorac Cardiovasc Surg. 2016;151:857-8.
    PubMed     Text format    


    February 2016
  97. ROCCO G, Nason K, Brunelli A, Varela G, et al
    Management of stage IIIA (N2) non-small cell lung cancer: A transatlantic perspective.
    J Thorac Cardiovasc Surg. 2016 Feb 27. pii: S0022-5223(16)00185.
    PubMed     Text format    


  98. KIM S
    Is there a need for a new staging system in early lung cancer?
    J Thorac Cardiovasc Surg. 2016 Feb 24. pii: S0022-5223(16)00372.
    PubMed     Text format    


  99. WILLIAMS M, Salerno T, Panos AL
    Right ventricular and epicardial tumors from benign metastasizing uterine leiomyoma.
    J Thorac Cardiovasc Surg. 2016;151:e21-4.
    PubMed     Text format    


  100. CEVASCO M, Yammine M, Aranki SF
    Cardiac tumors: To treat or not to treat (or both)?
    J Thorac Cardiovasc Surg. 2016;151:e25-6.
    PubMed     Text format    


    January 2016
  101. CHO H, Lee HY
    Is preoperative positron emission tomography-computed tomography a useful diagnostic or staging tool for pure ground glass opacity nodular adenocardinomas?
    J Thorac Cardiovasc Surg. 2016;151:280-1.
    PubMed     Text format    


  102. BAISI A, Raveglia F, Cioffi U
    Preoperative positron emission tomography/computed tomography in pulmonary ground glass opacities: A useful diagnostic and staging tool or not?
    J Thorac Cardiovasc Surg. 2016;151:279-80.
    PubMed     Text format    


  103. RUSCH VW
    Perioperative pharmacotherapy for lung resection: "Going for the gold"?
    J Thorac Cardiovasc Surg. 2016;151:18-9.
    PubMed     Text format    


    December 2015
  104. AZZI AJ, Shah K, Seely A, Villeneuve JP, et al
    Surgical team turnover and operative time: An evaluation of operating room efficiency during pulmonary resection.
    J Thorac Cardiovasc Surg. 2015 Dec 23. pii: S0022-5223(15)02534.
    PubMed     Text format     Abstract available


  105. YANG CJ, Kumar A, Gulack BC, Mulvihill MS, et al
    Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
    J Thorac Cardiovasc Surg. 2015 Dec 21. pii: S0022-5223(15)02522.
    PubMed     Text format     Abstract available


  106. MURTHY SC
    Lung cancer screening: Dollars and scents.
    J Thorac Cardiovasc Surg. 2015;150:1525.
    PubMed     Text format    


  107. NASON KS
    A call to arms against an enemy yet unknown.
    J Thorac Cardiovasc Surg. 2015;150:1506-7.
    PubMed     Text format    



  108. Discussion.
    J Thorac Cardiovasc Surg. 2015;150:1522-4.
    PubMed     Text format    


  109. HANNA WC
    N2 is not N2 is not N2.
    J Thorac Cardiovasc Surg. 2015;150:1494-5.
    PubMed     Text format    


    October 2015
  110. VAN BERKEL V
    Too many nodules: Can we do better than computed tomography screening for lung cancer?
    J Thorac Cardiovasc Surg. 2015 Oct 23. pii: S0022-5223(15)02110.
    PubMed     Text format    


  111. REDDY RM, Murlidhar V, Zhao L, Grabauskiene S, et al
    Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2015 Oct 22. pii: S0022-5223(15)01976.
    PubMed     Text format     Abstract available


  112. RIPLEY RT, Suzuki K, Tan KS, Adusumilli PS, et al
    Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2015 Oct 19. pii: S0022-5223(15)01979.
    PubMed     Text format     Abstract available


  113. LI H, Hu H, Wang R, Li Y, et al
    Lung adenocarcinoma: Are skip N2 metastases different from non-skip?
    J Thorac Cardiovasc Surg. 2015;150:790-5.
    PubMed     Text format     Abstract available


  114. PIO R, Agorreta J, Montuenga LM
    Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes.
    J Thorac Cardiovasc Surg. 2015;150:986-92.
    PubMed     Text format     Abstract available


  115. SINGHAL S
    A new tool in the medical bag shows promise.
    J Thorac Cardiovasc Surg. 2015;150:804-5.
    PubMed     Text format    


    September 2015
  116. REDWAN B, Ziegeler S, Dickgreber N, Fischer S, et al
    Metastasectomy in a lung graft using high-flow venovenous extracorporeal lung support in a patient after single lung transplantation.
    J Thorac Cardiovasc Surg. 2015 Sep 24. pii: S0022-5223(15)01547.
    PubMed     Text format    


  117. NG T
    An important first step in the evaluation of venous thromboembolism after pulmonary resection.
    J Thorac Cardiovasc Surg. 2015 Sep 11. pii: S0022-5223(15)01563.
    PubMed     Text format    


  118. LIU L, Liu C
    Need for conversion of video-assisted thoracoscopic surgery is not an insurmountable barrier.
    J Thorac Cardiovasc Surg. 2015;150:740.
    PubMed     Text format    


  119. JONES DR
    Do we know bad science when we see it?
    J Thorac Cardiovasc Surg. 2015;150:472-3.
    PubMed     Text format    


  120. RAJESWARAN J, Blackstone EH
    Patient-reported outcomes and importance of their appropriate statistical analyses.
    J Thorac Cardiovasc Surg. 2015;150:461-2.
    PubMed     Text format    


  121. TONG BC
    A stitch (or scan) in time saves nine.
    J Thorac Cardiovasc Surg. 2015;150:529-30.
    PubMed     Text format    



  122. Discussion.
    J Thorac Cardiovasc Surg. 2015;150:512-3.
    PubMed     Text format    


  123. CHO H, Lee HY, Kim J, Kim HK, et al
    Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
    J Thorac Cardiovasc Surg. 2015;150:514-20.
    PubMed     Text format     Abstract available


  124. CAMERON RB
    Measuring postoperative patient outcomes: Who knows best?
    J Thorac Cardiovasc Surg. 2015;150:619-20.
    PubMed     Text format    


  125. CAMERON RB
    Who left the PETs out?--Who?--Who?
    J Thorac Cardiovasc Surg. 2015;150:521-2.
    PubMed     Text format    


  126. FAGUNDES CP, Shi Q, Vaporciyan AA, Rice DC, et al
    Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.
    J Thorac Cardiovasc Surg. 2015;150:613-9.
    PubMed     Text format     Abstract available


    June 2015
  127. COHEN RG
    The patent internal thoracic artery graft: Increased degree of difficulty for left-sided pulmonary resections.
    J Thorac Cardiovasc Surg. 2015 Jun 30. pii: S0022-5223(15)01057.
    PubMed     Text format    


  128. WEI B, Broussard B, Bryant A, Linsky P, et al
    Left upper lobectomy after coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2015 Jun 6. pii: S0022-5223(15)00880.
    PubMed     Text format     Abstract available


    May 2015
  129. FARAONI D
    Fibrinogen concentrate as first-line therapy in children undergoing cardiac surgery: Promising perspectives.
    J Thorac Cardiovasc Surg. 2015;149:1466-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: